Pavlo Khodakivskyi

ORCID: 0000-0002-9230-5412
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • bioluminescence and chemiluminescence research
  • Cancer, Lipids, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Fluorine in Organic Chemistry
  • Advanced biosensing and bioanalysis techniques
  • Clostridium difficile and Clostridium perfringens research
  • Gut microbiota and health
  • Synthesis and Reactions of Organic Compounds
  • Peptidase Inhibition and Analysis
  • Nanoplatforms for cancer theranostics
  • Pancreatic function and diabetes
  • RNA Interference and Gene Delivery
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Epigenetics and DNA Methylation
  • PARP inhibition in cancer therapy
  • Protease and Inhibitor Mechanisms
  • Biotin and Related Studies
  • Calcium signaling and nucleotide metabolism
  • Orthopedic Infections and Treatments
  • Mesenchymal stem cell research
  • Cancer Cells and Metastasis
  • Infant Nutrition and Health
  • Glioma Diagnosis and Treatment
  • Advanced Fluorescence Microscopy Techniques

University of Missouri
2021-2025

École Polytechnique Fédérale de Lausanne
2016-2022

Taras Shevchenko National University of Kyiv
2019

FujiFilm VisualSonics (Canada)
2016

Johns Hopkins University
2016

Regeneron (United States)
2016

Community Options (United States)
2016

Pfizer (United States)
2016

Stemnion (United States)
2016

Despite advances in breast cancer therapy, effective targeting of stem cells (CSCs) remains a challenge. CSCs, which have self-renewal, tumorigenic and metastatic properties, are often quiescent located hypoxic regions tumors [1], making them resistant to conventional chemo- radiotherapies [2]. These characteristics allow CSCs survive, leading relapse metastasis. Studying under conditions similar their niche is essential for evaluating therapies that target these cells. We show can be...

10.1002/cac2.70018 article EN cc-by-nc-nd Cancer Communications 2025-03-20

The microbiome-produced enzyme bile salt hydrolase (BSH) plays a central role in human health, but its function remains unclear due to the lack of suitable methods for measuring activity. Here, we have developed novel optical tool based on ultrasensitive bioluminescent imaging and demonstrated that this assay can be used quick cost-effective quantification BSH activity across broad range biological settings including pure enzymes bacteria, intact fecal slurries, noninvasive live animals, as...

10.1126/sciadv.aaz9857 article EN cc-by-nc Science Advances 2021-02-03

Bioluminescent imaging (BLI) is one of the most powerful and widely used preclinical modalities. However, current technology relies on use transgenic luciferase-expressing cells animals therefore can only be applied to a limited number existing animal models human disease. Here, we report development "portable bioluminescent" (PBL) that overcomes major limitations traditional BLI. We demonstrate PBL method capable noninvasive measuring activity both extracellular (e.g., dipeptidyl peptidase...

10.1038/s41467-021-22892-9 article EN cc-by Nature Communications 2021-05-11

Diagnosing prosthetic joint infection (PJI) poses significant challenges, and current modalities are fraught with low sensitivity and/or potential morbidity. Photoacoustic imaging (PAI) is a novel ultrasound-based modality for diagnosing PJI safely noninvasively.In an established preclinical mouse model of bioluminescent Staphylococcus aureus PJI, fluorescent indocyanine green (ICG) was conjugated to β-cyclodextrin (CDX-ICG) or teicoplanin (Teic-ICG) injected intravenously 1 week...

10.5435/jaaos-d-16-00630 article EN Journal of the American Academy of Orthopaedic Surgeons 2016-12-09

Cancer stem cells (CSCs) drive tumorigenesis, are responsible for metastasis, and resist conventional therapies thus posing significant treatment challenges. CSCs reside in hypoxic tumor regions therefore, effective must target within this specific microenvironment. characterized by limited distinguishable features, however, surface displayed phosphatidylserine (PS) appears to be characteristic of offers a potential target. GlaS, truncated coagulation protein that is internalized after...

10.1101/2024.01.12.575071 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2024-01-15

Abstract Altered lipid metabolism is a common hallmark of various cancers, including intrahepatic cholangiocarcinoma (ICC), highly lethal carcinoma that lacks effective treatment options. To elucidate the changes in ICC, we coupled expression firefly luciferase gene (FFL) to AKT1 (AKT-FFL) via an IRES linker, and then hydrodynamically injected mice with AKT-FFL Notch1 intracellular cytoplasmic domain (NICD) establish luciferase-positive ICC model. This model not only enabled us monitor...

10.1158/1541-7786.mcr-23-0389 article EN Molecular Cancer Research 2024-02-15

Abstract The kidney’s inherent complexity has made identifying cell-specific pathways challenging, particularly when temporally associating them with the dynamic pathophysiology of acute kidney injury (AKI). Here, we combine renal luciferase reporter mice using a chemoselective luciferin to guide acquisition transcriptional changes in C57BL/6 background mice. Hydrogen peroxide generation, common mechanism tissue damage, was tracked peroxy-caged-luciferin identify optimum time points for...

10.1038/s42003-019-0571-7 article EN cc-by Communications Biology 2019-09-02

The microorganisms colonizing the gastrointestinal tract of animals, collectively referred to as gut microbiome, affect numerous host behaviors dependent on central nervous system (CNS). Studies comparing germ-free mice normally colonized have demonstrated influences microbiome anxiety-related behaviors, voluntary activity, and gene expression in CNS. Additionally, there is epidemiologic evidence supporting an intergenerational influence maternal neurodevelopment offspring behavior later...

10.1101/2024.04.12.589237 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-04-12

Cathepsin D is an aspartic protease and one of the most abundant proteases. It overexpressed in many cancers plays important role tumor development, progression, metastasis. While it a physiologically intracellular protein, cathepsin secreted into extracellular matrix under pathological conditions, making appealing target for drug delivery systems. Here, we present development evaluation new system targeting based on immunoliposomes functionalized with pepstatin A—a natural peptide inhibitor...

10.3390/pharmaceutics15102464 article EN cc-by Pharmaceutics 2023-10-14

<div>Abstract<p>Altered lipid metabolism is a common hallmark of various cancers, including intrahepatic cholangiocarcinoma (ICC), highly lethal carcinoma that lacks effective treatment options. To elucidate the changes in ICC, we coupled expression firefly luciferase gene (FFL) to <i>AKT1</i> (<i>AKT-FFL</i>) via an IRES linker, and then hydrodynamically injected mice with AKT-FFL <i>Notch1</i> intracellular cytoplasmic domain...

10.1158/1541-7786.c.7267993.v1 preprint EN 2024-06-04

<div>Abstract<p>Altered lipid metabolism is a common hallmark of various cancers, including intrahepatic cholangiocarcinoma (ICC), highly lethal carcinoma that lacks effective treatment options. To elucidate the changes in ICC, we coupled expression firefly luciferase gene (FFL) to <i>AKT1</i> (<i>AKT-FFL</i>) via an IRES linker, and then hydrodynamically injected mice with AKT-FFL <i>Notch1</i> intracellular cytoplasmic domain...

10.1158/1541-7786.c.7267993 preprint EN 2024-06-04

Abstract BACKGROUND Glioblastoma (GBM) is the most aggressive primary tumor of brain with a median survival 15 months. Maximal safe resection initial standard-of-care, but limited by diffuse invasiveness tumor. Fluorescence imaging has been shown to aid intra-operative identification, current options fail do so consistently. Recent literature fatty acid (FA) metabolism and uptake be altered in glioblastoma. For this reason, we introduce novel, near-infrared fluorescent dye, fatty-acid...

10.1093/neuonc/noad137.162 article EN Neuro-Oncology 2023-09-01
Coming Soon ...